AI retinal screening that scales public health impact.
Detect diabetic retinopathy earlier, expand screening coverage, and triage referrals faster. Designed for integration with real screening programs and real camera workflows — not just a model in a notebook.
Why retinal screening doesn't scale
The bottleneck isn't a missing AI — it's the absence of program operations around it.
Sight-threatening disease detected too late
Diabetic retinopathy is silent until it isn't. By the time a patient presents with symptoms, the window for early intervention has closed.
Specialist bottleneck
You can't hire your way out of the gap between diabetic-population growth and ophthalmology capacity — every screening still queues for a single specialist's eyes.
Slow, paper-based reporting
A screening done on Monday lands as a clinic letter on Friday — by which point the patient is gone and the loop is broken.
Models without program operations
Plenty of vendors sell “a model.” Almost none ship the camera workflow, governance, follow-up and reporting that turn it into screening at scale.
For Clinicians
- Earlier detection of sight-threatening disease
- Standardised reporting and prioritisation
- Better referral routing — fewer overloaded ophthalmology clinics
- Usable screening outputs that support clinical decision flow
For Operators & Executives
- Expands screening capacity without adding specialists
- Reduces avoidable blindness burden and downstream cost
- Integrates into screening programs, clinics and private networks
- Built for multi-site rollout and program governance
What It Is
Built for real workflows, not slide decks.
DR MATA is Qmed Asia's ophthalmology screening platform for automated diabetic retinopathy assessment, designed to integrate with fundus camera workflows and structured reporting.
Core Capabilities
A screening program, not just a model
Built so a fundus image becomes a triaged, tracked, follow-upable screening event — not a PDF in someone's inbox.
Camera-workflow integration
Plugs into the actual fundus cameras and screening flows your sites already use — no “export the file and email it” gymnastics.
- Direct fundus camera ingestion
- Site-by-site rollout patterns
- Multi-vendor compatibility
AI-graded screening
Automated diabetic-retinopathy assessment with structured outputs — not a confidence score that no clinician can act on.
- Structured grade output
- Triage-ready summary
- Quality-flag detection
Triage routing
High-risk cases are flagged for urgent specialist review; lower-risk cases are scheduled into routine follow-up — automatically.
- Urgent vs routine routing
- Specialty referral hand-off
- Follow-up tracking
Program operations
Reporting, dashboards and tracking designed for a screening program manager — not just an individual clinician.
- Program-level dashboards
- Coverage tracking
- Recall & follow-up workflows
Audit-ready outputs
Every grading is traceable, exportable and auditable for QA, research and compliance.
- Per-image audit trail
- Versioned model output
- Exportable QA bundle
Governed model updates
Models are version-controlled, with controlled rollout and rollback — your screening program never wakes up to a silent change.
- Version-controlled models
- Controlled rollout
- Rollback & audit
From fundus to follow-up
Four steps that turn a screening photo into a managed clinical pathway.
Capture
Fundus image is captured at the screening site (clinic, primary care, or mobile camp).
AI assess
Image is graded automatically with structured output and quality flags.
Triage
Result is routed — urgent specialist review, routine follow-up, or repeat-screen schedule.
Track & recall
Patient is tracked through follow-up; recall is automated when due.
The DR MATA advantage
Operational, financial and patient-experience improvements you can measure in weeks, not quarters.
Operational
- Higher screening throughput per site
- Lower ophthalmology overload from low-risk cases
- Reliable follow-up tracking
Financial
- Lower downstream cost from late-stage disease
- Better-deployed specialist capacity
- Program-level efficiency at scale
Patient Experience
- Earlier detection, better outcomes
- Faster, clearer screening result
- Reliable follow-up and recall
Outcomes & KPIs
Outcomes you can measure.
We design every deployment to deliver measurable change — not just a feature list.
Screening throughput per day per site
Referral conversion and prioritisation quality
Reduced ophthalmology overload for low-risk cases
Screening coverage expansion and follow-up compliance
Deployment
- Edge or server-based deployment depending on site constraints
- Multi-site management and program dashboards
- Camera workflow integration patterns
Security & Governance
- ISO-aligned quality and security practices
- Audit trail for screening workflow
- Controlled model updates and governance workflows
The plain truth.
A screening AI without program operations is not a solution. DR MATA is positioned as a full screening workflow platform — not just a model.
Ready to deploy DR MATA?
Talk to our team about your hospital's rollout. We'll scope a pilot that fits your reality — not a generic demo.